Références Bibliographiques :
Aalfs, J.D. and Kingston, R.E. (2000) What does 'chromatin remodeling' mean? Trends Biochem Sci, 25, 548-555.
Adamson, A.L. and Kenney, S. (1999) The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein. J. Virol., 73, 6551-6558.
Agalioti, T., Lomvardas, S., Parekh, B., Yie, J., Maniatis, T. and Thanos, D. (2000) Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter. Cell, 103, 667-678.
Akerman, G.S., Tolleson, W.H., Brown, K.L., Zyzak, L.L., Mourateva, E., Engin, T.S., Basaraba, A., Coker, A.L., Creek, K.E. and Pirisi, L. (2001) Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes. Cancer Res, 61, 3837-3843.
Alexiadis, V., Varga-Weisz, P.D., Bonte, E., Becker, P.B. and Gruss, C. (1998) in vitro chromatin remodelling by chromatin accessibility complex (CHRAC) at the SV40 origin of DNA replication. EMBO J., 17, 3428-3438.
Andersen, B., Hariri, A., Pittelkow, M.R. and Rosenfeld, M.G. (1997a) Characterization of Skn-1a/i POU domain factors and linkage to papillomavirus gene expression. J Biol Chem, 272, 15905-15913.
Andersen, B. and Rosenfeld, M.G. (2001) POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human disease. Endocr Rev, 22, 2-35.
Andersen, B., Weinberg, W.C., Rennekampff, O., McEvilly, R.J., Bermingham, J.R., Jr., Hooshmand, F., Vasilyev, V., Hansbrough, J.F., Pittelkow, M.R., Yuspa, S.H. and Rosenfeld, M.G. (1997b) Functions of the POU domain genes Skn-1a/i and Tst-1/Oct-6/SCIP in epidermal differentiation. Genes Dev, 11, 1873-1884.
Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R.J., Rahmsdorf, H.J., Jonat, C., Herrlich, P. and Karin, M. (1987) Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell, 49, 729-739.
Angel, P., Szabowski, A. and Schorpp-Kistner, M. (2001) Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene, 20, 2413-2423.
Annunziato, A.T. and Hansen, J.C. (2000) Role of histone acetylation in the assembly and modulation of chromatin structures. Gene Expr, 9, 37-61.
Antonsson, A., Forslund, O., Ekberg, H., Sterner, G. and Hansson, B.G. (2000) The Ubiquity and Impressive Genomic Diversity of Human Skin Papillomaviruses Suggest a Commensalic Nature of These Viruses. J. Virol., 74, 11636-11641.
Antson, A.A., Burns, J.E., Moroz, O.V., Scott, D.J., Sanders, C.M., Bronstein, I.B., Dodson, G.G., Wilson, K.S. and Maitland, N.J. (2000) Structure of the intact transactivation domain of the human papillomavirus E2 protein. Nature, 403, 805-809.
Apt, D., Chong, T., Liu, Y. and Bernard, H.U. (1993) Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16. J. Virol., 67, 4455-4463.
Arany, Z., Sellers, W.R., Livingston, D.M. and Eckner, R. (1994) E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell, 77, 799-800.
Aravind, L. and Landsman, D. (1998) AT-hook motifs identified in a wide variety of DNA-binding proteins. Nucleic Acids Res., 26, 4413-4421.
Arias, J., Alberts, A.S., Brindle, P., Claret, F.X., Smeal, T., Karin, M., Feramisco, J. and Montminy, M. (1994) Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature, 370, 226-229.
Bannister, A.J. and Kouzarides, T. (1995) CBP-induced stimulation of c-Fos activity is abrogated by E1A. EMBO J., 14, 4758-4762.
Bannister, A.J. and Kouzarides, T. (1996) The CBP co-activator is a histone acetyltransferase. Nature, 384, 641-643.
Bannister, A.J., Oehler, T., Wilhelm, D., Angel, P. and Kouzarides, T. (1995) Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene, 11, 2509-2514.
Barbosa, M.S., Edmonds, C., Fisher, C., Schiller, J.T., Lowy, D.R. and Vousden, K.H. (1990) The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. EMBO J., 9, 153-160.
Barbosa, M.S. and Schlegel, R. (1989) The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene, 4, 1529-1532.
Barnard, P., Payne, E. and McMillan, N.A. (2000) The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon-alpha. Virology, 277, 411-419.
Bedell, M.A., Jones, K.H., Grossman, S.R. and Laimins, L.A. (1989) Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells. J. Virol., 63, 1247-1255.
Bednar, J., Horowitz, R.A., Grigoryev, S.A., Carruthers, L.M., Hansen, J.C., Koster, A.J. and Woodcock, C.L. (1998) Nucleosomes, linker DNA, and linker histone form a unique structural motif that directs the higher-order folding and compaction of chromatin. Proc Natl Acad Sci U S A, 95, 14173-14178.
Beger, M., Butz, K., Denk, C., Williams, T., Hurst, H.C. and Hoppe-Seyler, F. (2001) Expression pattern of AP-2 transcription factors in cervical cancer cells and analysis of their influence on human papillomavirus oncogene transcription. J Mol Med, 79, 314-320.
Bellanger, S., Demeret, C., Goyat, S. and Thierry, F. (2001) Stability of the Human Papillomavirus Type 18 E2 Protein Is Regulated by a Proteasome Degradation Pathway through Its Amino-Terminal Transactivation Domain. J. Virol., 75, 7244-7251.
Benbrook, D.M. and Jones, N.C. (1990) Heterodimer formation between CREB and JUN proteins. Oncogene, 5, 295-302.
Beresford, G.W. and Boss, J.M. (2001) CIITA coordinates multiple histone acetylation modifications at the HLA- DRA promoter. Nat Immunol, 2, 652-657.
Berger, S.L. (2001) An embarrassment of niches: the many covalent modifications of histones in transcriptional regulation. Oncogene, 20, 3007-3013.
Berkhout, B., Gatignol, A., Rabson, A.B. and Jeang, K.T. (1990) TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter. Cell, 62, 757-767.
Bernard, B.A., Bailly, C., Lenoir, M.C., Darmon, M., Thierry, F. and Yaniv, M. (1989) The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. J. Virol., 63, 4317-4324.
Berumen, J., Casas, L., Segura, E., Amezcua, J.L. and Garcia-Carranca, A. (1994) Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes. Int J Cancer, 56, 640-645.
Bex, F. and Gaynor, R.B. (1998) Regulation of gene expression by HTLV-I Tax protein. Methods, 16, 83-94.
Blackwood, E.M. and Kadonaga, J.T. (1998) Going the distance: a current view of enhancer action. Science, 281, 61-63.
Boisvert, F.M., Kruhlak, M.J., Box, A.K., Hendzel, M.J. and Bazett-Jones, D.P. (2001) The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J Cell Biol, 152, 1099-1106.
Bosher, J.M., Williams, T. and Hurst, H.C. (1995) The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc Natl Acad Sci U S A, 92, 744-747.
Bouallaga, I., Massicard, S., Yaniv, M. and Thierry, F. (2000) An enhanceosome containing the Jun B/Fra-2 heterodimer and the HMG-I(Y) architectural protein controls HPV 18 transcription. EMBO Rep, 1, 422-427.
Bouallaga, I. and Thierry, F. (1999) Control of Human Papillomavirus type 18 transcription: role in carcinogenesis. Recent Research Developments in Virology, 1, 369-383.
Boyer, S.N., Wazer, D.E. and Band, V. (1996) E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res, 56, 4620-4624.
Brand, M., Leurent, C., Mallouh, V., Tora, L. and Schultz, P. (1999) Three-dimensional structures of the TAFII-containing complexes TFIID and TFTC. Science, 286, 2151-2153.
Breathnach, R. and Chambon, P. (1981) Organization and expression of eucaryotic split genes coding for proteins. Annu Rev Biochem, 50, 349-383.
Breiding, D.E., Sverdrup, F., Grossel, M.J., Moscufo, N., Boonchai, W. and Androphy, E.J. (1997) Functional interaction of a novel cellular protein with the papillomavirus E2 transactivation domain. Mol Cell Biol, 17, 7208-7219.
Brown, K.E., Baxter, J., Graf, D., Merkenschlager, M. and Fisher, A.G. (1999) Dynamic repositioning of genes in the nucleus of lymphocytes preparing for cell division. Mol Cell, 3, 207-217.
Brown, K.E., Guest, S.S., Smale, S.T., Hahm, K., Merkenschlager, M. and Fisher, A.G. (1997) Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell, 91, 845-854.
Brunvand, M.W., Krumm, A. and Groudine, M. (1993) in vivo footprinting of the human IL-2 gene reveals a nuclear factor bound to the transcription start site in T cells. Nucleic Acids Res., 21, 4824-4829.
Bryan, J.T., Han, A., Fife, K.H. and Brown, D.R. (2000) The human papillomavirus type 11 E1E4 protein is phosphorylated in genital epithelium. Virology, 268, 430-439.
Bryant, L.A., Mixon, P., Davidson, M., Bannister, A.J., Kouzarides, T. and Sinclair, J.H. (2000) The human cytomegalovirus 86-kilodalton major immediate-early protein interacts physically and functionally with histone acetyltransferase P/CAF. J. Virol., 74, 7230-7237.
Bucher, P. (1990) Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J Mol Biol, 212, 563-578.
Burke, T.W. and Kadonaga, J.T. (1996) Drosophila TFIID binds to a conserved downstream basal promoter element that is present in many TATA-box-deficient promoters. Genes Dev, 10, 711-724.
Burke, T.W. and Kadonaga, J.T. (1997) The downstream core promoter element, DPE, is conserved from Drosophila to humans and is recognized by TAFII60 of Drosophila. Genes Dev, 11, 3020-3031.
Burke, T.W., Willy, P.J., Kutach, A.K., Butler, J.E. and Kadonaga, J.T. (1998) The DPE, a conserved downstream core promoter element that is functionally analogous to the TATA box. Cold Spring Harb Symp Quant Biol, 63, 75-82.
Bustin, M. (1999) Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol, 19, 5237-5246.
Bustin, M. (2001a) Chromatin unfolding and activation by HMGN(*) chromosomal proteins. Trends Biochem Sci, 26, 431-437.
Bustin, M. (2001b) Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem Sci, 26, 152-153.
Bustin, M. and Reeves, R. (1996) High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol, 54, 35-100.
Butscher, W.G., Haggerty, C.M., Chaudhry, S. and Gardner, K. (2001) Targeting of p300 to the Interleukin-2 promoter via CREB/Rel cross-talk during mitogen and oncogenic molecular signaling in activated T-cells. J Biol Chem, 19, 19.
Butz, K. and Hoppe-Seyler, F. (1993) Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region. J. Virol., 67, 6476-6486.
Carey, M. (1998) The enhanceosome and transcriptional synergy. Cell, 92, 5-8.
Carvalho, T., Seeler, J.S., Ohman, K., Jordan, P., Pettersson, U., Akusjarvi, G., Carmo-Fonseca, M. and Dejean, A. (1995) Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix- associated PML bodies. J Cell Biol, 131, 45-56.
Caswell, R., Bryant, L. and Sinclair, J. (1996) Human cytomegalovirus immediate-early 2 (IE2) protein can transactivate the human hsp70 promoter by alleviation of Dr1-mediated repression. J. Virol., 70, 4028-4037.
Chalkley, G.E. and Verrijzer, C.P. (1999) DNA binding site selection by RNA polymerase II TAFs: a TAF(II)250- TAF(II)150 complex recognizes the initiator. EMBO J., 18, 4835-4845.
Chau, K.Y., Munshi, N., Keane-Myers, A., Cheung-Chau, K.W., Tai, A.K., Manfioletti, G., Dorey, C.K., Thanos, D., Zack, D.J. and Ono, S.J. (2000) The architectural transcription factor high mobility group I(Y) participates in photoreceptor-specific gene expression. J Neurosci, 20, 7317-7324.
Chaudhry, A.Z., Vitullo, A.D. and Gronostajski, R.M. (1999) Nuclear factor I-mediated repression of the mouse mammary tumor virus promoter is abrogated by the coactivators p300/CBP and SRC-1. J Biol Chem, 274, 7072-7081.
Chen, D. and Zhou, Q. (1999) Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase. Mol Cell Biol, 19, 2863-2871.
Chen, H., Lin, R.J., Schiltz, R.L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M.L., Nakatani, Y. and Evans, R.M. (1997) Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell, 90, 569-580.
Chen, J.D. and Evans, R.M. (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature, 377, 454-457.
Chen, P.H., Tseng, W.B., Chu, Y. and Hsu, M.T. (2000) Interference of the simian virus 40 origin of replication by the cytomegalovirus immediate early gene enhancer: evidence for competition of active regulatory chromatin conformation in a single domain. Mol Cell Biol, 20, 4062-4074.
Cheung, P., Tanner, K.G., Cheung, W.L., Sassone-Corsi, P., Denu, J.M. and Allis, C.D. (2000) Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol Cell, 5, 905-915.
Chi, T. and Carey, M. (1993) The ZEBRA activation domain: modular organization and mechanism of action. Mol Cell Biol, 13, 7045-7055.
Chi, T., Lieberman, P., Ellwood, K. and Carey, M. (1995) A general mechanism for transcriptional synergy by eukaryotic activators. Nature, 377, 254-257.
Cho, H., Orphanides, G., Sun, X., Yang, X.J., Ogryzko, V., Lees, E., Nakatani, Y. and Reinberg, D. (1998) A human RNA polymerase II complex containing factors that modify chromatin structure. Mol Cell Biol, 18, 5355-5363.
Cho, Y., Kang, J., Cho, M., Cho, C., Lee, S., Choe, Y., Kim, Y., Choi, I., Park, S., Kim, S., Dinarello, C.A. and Yoon, D. (2001) Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18. FEBS Lett, 501, 139-145.
Chong, T., Apt, D., Gloss, B., Isa, M. and Bernard, H.U. (1991) The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription. J. Virol., 65, 5933-5943.
Cook, P.R. (1999) The organization of replication and transcription. Science, 284, 1790-1795.
Cremer, T. and Cremer, C. (2001) Chromosome territories, nuclear architecture and gene regulation in mammalian cells. Nat Rev Genet, 2, 292-301.
Croft, J.A., Bridger, J.M., Boyle, S., Perry, P., Teague, P. and Bickmore, W.A. (1999) Differences in the localization and morphology of chromosomes in the human nucleus. J Cell Biol, 145, 1119-1131.
Cueille, N., Nougarede, R., Mechali, F., Philippe, M. and Bonne-Andrea, C. (1998) Functional interaction between the bovine papillomavirus virus type 1 replicative helicase E1 and cyclin E-Cdk2. J. Virol., 72, 7255-7262.
D'Anna, R., Le Buanec, H., Bizzini, B., Burny, A., Giannouli, C., Zagury, J.F., Gallo, R.C., Zagury, D. and D'Alessio, P. (2001) Human papillomavirus-16-E7 oncoprotein enhances the expression of adhesion molecules in cervical endothelial cells but not in human umbilical vein endothelial cells. J Hum Virol, 4, 85-95.
Darst, R.P., Wang, D. and Auble, D.T. (2001) MOT1-catalyzed TBP-DNA disruption: uncoupling DNA conformational change and role of upstream DNA. EMBO J., 20, 2028-2040.
Davidson, I., Xiao, J.H., Rosales, R., Staub, A. and Chambon, P. (1988) The HeLa cell protein TEF-1 binds specifically and cooperatively to two SV40 enhancer motifs of unrelated sequence. Cell, 54, 931-942.
Degenhardt, Y.Y. and Silverstein, S.J. (2001) Gps2, a protein partner for human papillomavirus E6 proteins. J. Virol., 75, 151-160.
Demeret, C., Desaintes, C., Yaniv, M. and Thierry, F. (1997) Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes. J. Virol., 71, 9343-9349.
Demeret, C., Goyat, S., Yaniv, M. and Thierry, F. (1998) The human papillomavirus type 18 (HPV18) replication protein E1 is a transcriptional activator when interacting with HPV18 E2. Virology, 242, 378-386.
Demeret, C., Le Moal, M., Yaniv, M. and Thierry, F. (1995) Control of HPV 18 DNA replication by cellular and viral transcription factors. Nucleic Acids Res., 23, 4777-4784.
Demeret, C. and Thierry, F. (personnal communication) .
Demeret, C., Yaniv, M. and Thierry, F. (1994) The E2 transcriptional repressor can compensate for Sp1 activation of the human papillomavirus type 18 early promoter. J. Virol., 68, 7075-7082.
Desaintes, C. and Demeret, C. (1996) Control of papillomavirus DNA replication and transcription. Semin Cancer Biol, 7, 339-347.
Desaintes, C., Demeret, C., Goyat, S., Yaniv, M. and Thierry, F. (1997) Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J., 16, 504-514.
Desaintes, C., Goyat, S., Garbay, S., Yaniv, M. and Thierry, F. (1999) Papillomavirus E2 induces p53-independent apoptosis in HeLa cells. Oncogene, 18, 4538-4545.
Desaintes, C., Hallez, S., Van Alphen, P. and Burny, A. (1992) Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16. J. Virol., 66, 325-333.
Ding, H.F., Bustin, M. and Hansen, U. (1997) Alleviation of histone H1-mediated transcriptional repression and chromatin compaction by the acidic activation region in chromosomal protein HMG-14. Mol Cell Biol, 17, 5843-5855.
Dollard, S.C., Wilson, J.L., Demeter, L.M., Bonnez, W., Reichman, R.C., Broker, T.R. and Chow, L.T. (1992) Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. OFF. Genes Dev, 6, 1131-1142.
Donehower, L.A. and Bradley, A. (1993) The tumor suppressor p53. Biochim Biophys Acta, 1155, 181-205.
Doorbar, J., Campbell, D., Grand, R.J. and Gallimore, P.H. (1986) Identification of the human papilloma virus-1a E4 gene products. EMBO J., 5, 355-362.
Dostatni, N., Lambert, P.F., Sousa, R., Ham, J., Howley, P.M. and Yaniv, M. (1991) The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex. Genes Dev, 5, 1657-1671.
Dostatni, N., Thierry, F. and Yaniv, M. (1988) A dimer of BPV-1 E2 containing a protease resistant core interacts with its DNA target. EMBO J., 7, 3807-3816.
Doucas, V. (2000) The promyelocytic (PML) nuclear compartment and transcription control. Biochem Pharmacol, 60, 1197-1201.
Duensing, S., Duensing, A., Crum, C.P. and Munger, K. (2001) Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype. Cancer Res, 61, 2356-2360.
Dynan, W.S. and Tjian, R. (1983) The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell, 35, 79-87.
Dyson, N., Buchkovich, K., Whyte, P. and Harlow, E. (1989a) The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell, 58, 249-255.
Dyson, N., Howley, P.M., Münger, K. and Harlow, E. (1989b) The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science, 243, 934-937.
Egan, C., Bayley, S.T. and Branton, P.E. (1989) Binding of the Rb1 protein to E1A products is required for adenovirus transformation. Oncogene, 4, 383-388.
el Kharroubi, A. and Martin, M.A. (1996) cis-acting sequences located downstream of the human immunodeficiency virus type 1 promoter affect its chromatin structure and transcriptional activity. Mol Cell Biol, 16, 2958-2966.
El Kharroubi, A., Piras, G., Zensen, R. and Martin, M.A. (1998) Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter. Mol Cell Biol, 18, 2535-2544.
Ellwood, K., Huang, W., Johnson, R. and Carey, M. (1999) Multiple layers of cooperativity regulate enhanceosome-responsive RNA polymerase II transcription complex assembly. Mol. Cell Biol., 19, 2613-2623.
Enemark, E.J., Chen, G., Vaughn, D.E., Stenlund, A. and Joshua-Tor, L. (2000) Crystal structure of the DNA binding domain of the replication initiation protein E1 from papillomavirus. Mol Cell, 6, 149-158.
Evander, M., Frazer, I.H., Payne, E., Qi, Y.M., Hengst, K. and McMillan, N.A. (1997) Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J. Virol., 71, 2449-2456.
Ewen, M.E., Sluss, H.K., Sherr, C.J., Matsushime, H., Kato, J. and Livingston, D.M. (1993) Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell, 73, 487-497.
Falvo, J.V., Uglialoro, A.M., Brinkman, B.M., Merika, M., Parekh, B.S., Tsai, E.Y., King, H.C., Morielli, A.D., Peralta, E.G., Maniatis, T., Thanos, D. and Goldfeld, A.E. (2000) Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter. Mol Cell Biol, 20, 2239-2247.
Fiering, S., Whitelaw, E. and Martin, D.I. (2000) To be or not to be active: the stochastic nature of enhancer action. Bioessays, 22, 381-387.
Foster, L.C., Wiesel, P., Huggins, G.S., Panares, R., Chin, M.T., Pellacani, A. and Perrella, M.A. (2000) Role of activating protein-1 and high mobility group-I(Y) protein in the induction of CD44 gene expression by interleukin-1beta in vascular smooth muscle cells. Faseb J, 14, 368-378.
Franklin, C.C., McCulloch, A.V. and Kraft, A.S. (1995) in vitro association between the Jun protein family and the general transcription factors, TBP and TFIIB. Biochem J, 305, 967-974.
French, S.W., Schmidt, M.C. and Glorioso, J.C. (1996) Involvement of a high-mobility-group protein in the transcriptional activity of herpes simplex virus latency-active promoter 2. Mol Cell Biol, 16, 5393-5399.
Fuchs, E. and Byrne, C. (1994) The epidermis: rising to the surface. Curr Opin Genet Dev, 4, 725-736.
Furukawa, T. and Tanese, N. (2000) Assembly of partial TFIID complexes in mammalian cells reveals distinct activities associated with individual TATA box-binding protein- associated factors. J Biol Chem, 275, 29847-29856.
Fushimi, K. and Verkman, A.S. (1991) Low viscosity in the aqueous domain of cell cytoplasm measured by picosecond polarization microfluorimetry. J Cell Biol, 112, 719-725.
Gangloff, Y., Romier, C., Thuault, S., Werten, S. and Davidson, I. (2001) The histone fold is a key structural motif of transcription factor TFIID. Trends Biochem Sci, 26, 250-257.
Gao, Q., Singh, L., Kumar, A., Srinivasan, S., Wazer, D.E. and Band, V. (2001) Human papillomavirus type 16 E6-induced degradation of E6TP1 correlates with its ability to immortalize human mammary epithelial cells. J. Virol., 75, 4459-4466.
Garber, M.E. and Jones, K.A. (1999) HIV-1 Tat: coping with negative elongation factors. Curr Opin Immunol, 11, 460-465.
Garcia-Carranca, A., Thierry, F. and Yaniv, M. (1988) Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18. J. Virol., 62, 4321-4330.
Gariglio, M., Foresta, P., Sacchi, C., Lembo, M., Hertel, L. and Landolfo, S. (1997) Suppression of high mobility group protein T160 expression impairs mouse cytomegalovirus replication. J Gen Virol, 78, 665-670.
Garraway, I.P., Semple, K. and Smale, S.T. (1996) Transcription of the lymphocyte-specific terminal deoxynucleotidyltransferase gene requires a specific core promoter structure. Proc Natl Acad Sci U S A, 93, 4336-4341.
Geisberg, J.V., Holstege, F.C., Young, R.A. and Struhl, K. (2001) Yeast NC2 associates with the RNA polymerase II preinitiation complex and selectively affects transcription in vivo. Mol Cell Biol, 21, 2736-2742.
Georgopoulos, N.T., Proffitt, J.L. and Blair, G.E. (2000) Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins. Oncogene, 19, 4930-4935.
Gewin, L. and Galloway, D.A. (2001) E Box-Dependent Activation of Telomerase by Human Papillomavirus Type 16 E6 Does Not Require Induction of c-myc. J. Virol., 75, 7198-7201.
Ghazal, P., Lubon, H. and Hennighausen, L. (1988a) Multiple sequence-specific transcription factors modulate cytomegalovirus enhancer activity in vitro. Mol Cell Biol, 8, 1809-1811.
Ghazal, P., Lubon, H. and Hennighausen, L. (1988b) Specific interactions between transcription factors and the promoter- regulatory region of the human cytomegalovirus major immediate-early gene. J. Virol., 62, 1076-1079.
Giebler, H.A., Loring, J.E., van Orden, K., Colgin, M.A., Garrus, J.E., Escudero, K.W., Brauweiler, A. and Nyborg, J.K. (1997) Anchoring of CREB binding protein to the human T-cell leukemia virus type 1 promoter: a molecular mechanism of Tax transactivation. Mol Cell Biol, 17, 5156-5164.
Giese, K., Kingsley, C., Kirshner, J.R. and Grosschedl, R. (1995) Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes & Dev., 9, 995-1008.
Giri, I. and Yaniv, M. (1988) Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveals three distinct functional domains. EMBO J., 7, 2823-2829.
Giroglou, T., Florin, L., Schafer, F., Streeck, R.E. and Sapp, M. (2001) Human papillomavirus infection requires cell surface heparan sulfate. J. Virol., 75, 1565-1570.
Gloss, B. and Bernard, H.U. (1990) The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant SP1 distal element. J. Virol., 64, 5577-5584.
Gloss, B., Bernard, H.U., Seedorf, K. and Klock, G. (1987) The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J., 6, 3735-3743.
Gloss, B., Chong, T. and Bernard, H.U. (1989) Numerous nuclear proteins bind the long control region of human papillomavirus type 16: a subset of 6 of 23 DNase I-protected segments coincides with the location of the cell-type-specific enhancer. J. Virol., 63, 1142-1152.
Gonzalez, S.L., Stremlau, M., He, X., Basile, J.R. and Munger, K. (2001) Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 e7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of e7. J. Virol., 75, 7583-7591.
Goodman, R.H. and Smolik, S. (2000) CBP/p300 in cell growth, transformation, and development. Genes Dev, 14, 1553-1577. immortalization functions associated with E1551A involve the inactivation of a family of related proteins that normally participate in second-messenger-regulated gene expression.
Green, M.R. (2000) TBP-associated factors (TAFIIs): multiple, selective transcriptional mediators in common complexes. Trends Biochem Sci, 25, 59-63.
Gronostajski, R.M. (2000) Roles of the NFI/CTF gene family in transcription and development. Gene, 249, 31-45.
Gronostajski, R.M., Adhya, S., Nagata, K., Guggenheimer, R.A. and Hurwitz, J. (1985) Site-specific DNA binding of nuclear factor I: analyses of cellular binding sites. Mol Cell Biol, 5, 964-971.
Gross, D.S. and Garrard, W.T. (1988) Nuclease hypersensitive sites in chromatin. Annu Rev Biochem, 57, 159-197.
Gu, W. and Roeder, R.G. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell, 90, 595-606.
Gupta, S., Barrett, T., Whitmarsh, A.J., Cavanagh, J., Sluss, H.K., Derijard, B. and Davis, R.J. (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J., 15, 2760-2770.
Hagemeier, C., Walker, S.M., Sissons, P.J. and Sinclair, J.H. (1992) The 72K IE1 and 80K IE2 proteins of human cytomegalovirus independently trans-activate the c-fos, c-myc and hsp70 promoters via basal promoter elements. J Gen Virol, 73, 2385-2393.
Hai, T. and Curran, T. (1991) Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci U S A, 88, 3720-3724.
Harrod, R., Kuo, Y.L., Tang, Y., Yao, Y., Vassilev, A., Nakatani, Y. and Giam, C.Z. (2000) p300 and p300/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi- histone acetyltransferase/activator-enhancer complex. J Biol Chem, 275, 11852-11857.
Hawley-Nelson, P., Androphy, E.J., Lowy, D.R. and Schiller, J.T. (1988) The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancer. EMBO J., 7, 525-531.
Hayhurst, G.P., Bryant, L.A., Caswell, R.C., Walker, S.M. and Sinclair, J.H. (1995) CCAAT box-dependent activation of the TATA-less human DNA polymerase alpha promoter by the human cytomegalovirus 72-kilodalton major immediate-early protein. J. Virol., 69, 182-188.
Heck, D.V., Yee, C.L., Howley, P.M. and Munger, K. (1992) Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc Natl Acad Sci U S A, 89, 4442-4446.
Hegde, R.S., Grossman, S.R., Laimins, L.A. and Sigler, P.B. (1992) Crystal structure at 1.7 A of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target. Nature, 359, 505-512.
Henderson, A., Bunce, M., Siddon, N., Reeves, R. and Tremethick, D.J. (2000) High-mobility-group protein I can modulate binding of transcription factors to the U5 region of the human immunodeficiency virus type 1 proviral promoter. J. Virol., 74, 10523-10534.
Henkel, T., Ling, P.D., Hayward, S.D. and Peterson, M.G. (1994) Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science, 265, 92-95.
Hilger-Eversheim, K., Moser, M., Schorle, H. and Buettner, R. (2000) Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene, 260, 1-12.
Hoffmann, A., Oelgeschlager, T. and Roeder, R.G. (1997) Considerations of transcriptional control mechanisms: do TFIID-core promoter complexes recapitulate nucleosome-like functions? Proc Natl Acad Sci U S A, 94, 8928-8935.
Hoppe-Seyler, F., Butz, K. and zur Hausen, H. (1991) Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1. J. Virol., 65, 5613-5618.
Horlein, A.J., Naar, A.M., Heinzel, T., Torchia, J., Gloss, B., Kurokawa, R., Ryan, A., Kamei, Y., Soderstrom, M., Glass, C.K. and et al. (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature, 377, 397-404.
Hou, S.Y., Wu, S.Y., Zhou, T., Thomas, M.C. and Chiang, C.M. (2000) Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex. Mol Cell Biol, 20, 113-125.
Howe, L., Brown, C.E., Lechner, T. and Workman, J.L. (1999) Histone acetyltransferase complexes and their link to transcription. Crit Rev Eukaryot Gene Expr, 9, 231-243.
Huibregtse, J.M., Scheffner, M. and Howley, P.M. (1993) Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell. Biol., 13, 775-784.
Hwang, E.S., Naeger, L.K. and DiMaio, D. (1996) Activation of the endogenous p53 growth inhibitory pathway in HeLa cervical carcinoma cells by expression of the bovine papillomavirus E2 gene. Oncogene, 12, 795-803.
Imagawa, M., Chiu, R. and Karin, M. (1987) Transcription factor AP-2 mediates induction by two different signal- transduction pathways: protein kinase C and cAMP. Cell, 51, 251-260.
Ishiji, T., Lace, M.J., Parkkinen, S., Anderson, R.D., Haugen, T.H., Cripe, T.P., Xiao, J.H., Davidson, I., Chambon, P. and Turek, L.P. (1992) Transcriptional enhancer factor (TEF)-1 and its cell-specific co- activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. EMBO J., 11, 2271-2281.
Jackson, S., Harwood, C., Thomas, M., Banks, L. and Storey, A. (2000) Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev, 14, 3065-3073.
Jakobovits, E.B., Bratosin, S. and Aloni, Y. (1980) A nucleosome-free region in SV40 minichromosomes. Nature, 285, 263-265.
Janknecht, R. and Hunter, T. (1996) Transcription. A growing coactivator network. Nature, 383, 22-23.
Javahery, R., Khachi, A., Lo, K., Zenzie-Gregory, B. and Smale, S.T. (1994) DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol Cell Biol, 14, 116-127.
Jiang, S.W., Desai, D., Khan, S. and Eberhardt, N.L. (2000) Cooperative binding of TEF-1 to repeated GGAATG-related consensus elements with restricted spatial separation and orientation. DNA Cell Biol, 19, 507-514.
John, S., Reeves, R.B., Lin, J.X., Child, R., Leiden, J.M., Thompson, C.B. and Leonard, W.J. (1995) Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins. Mol. Cell. Biol., 15, 1786-1796.
Kalantari, M., Karlsen, F., Kristensen, G., Holm, R., Hagmar, B. and Johansson, B. (1998) Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis. Int J Gynecol Pathol, 17, 146-153.
Kashanchi, F., Piras, G., Radonovich, M.F., Duvall, J.F., Fattaey, A., Chiang, C.M., Roeder, R.G. and Brady, J.N. (1994) Direct interaction of human TFIID with the HIV-1 transactivator tat. Nature, 367, 295-299.
Katich, S.C., Zerfass-Thome, K. and Hoffmann, I. (2001) Regulation of the Cdc25A gene by the human papillomavirus Type 16 E7 oncogene. Oncogene, 20, 543-550.
Kim, S.S., Tam, J.K., Wang, A.F. and Hegde, R.S. (2000) The structural basis of DNA target discrimination by papillomavirus E2 proteins. J Biol Chem, 275, 31245-31254.
Kim, T.K. and Roeder, R.G. (1994) Proline-rich activator CTF1 targets the TFIIB assembly step during transcriptional activation. Proc Natl Acad Sci U S A, 91, 4170-4174.
Kleff, S., Andrulis, E.D., Anderson, C.W. and Sternglanz, R. (1995) Identification of a gene encoding a yeast histone H4 acetyltransferase. J Biol Chem, 270, 24674-24677.
Klein-Hessling, S., Schneider, G., Heinfling, A., Chuvpilo, S. and Serfling, E. (1996) HMG I(Y) interferes with the DNA binding of NF-AT factors and the induction of the interleukin 4 promoter in T cells. Proc Natl Acad Sci U S A, 93, 15311-15316.
Klemm, J.D., Rould, M.A., Aurora, R., Herr, W. and Pabo, C.O. (1994) Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell, 77, 21-32.
Kyriakis, J.M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E.A., Ahmad, M.F., Avruch, J. and Woodgett, J.R. (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature, 369, 156-160.
Lagrange, T., Kapanidis, A.N., Tang, H., Reinberg, D. and Ebright, R.H. (1998) New core promoter element in RNA polymerase II-dependent transcription: sequence-specific DNA binding by transcription factor IIB. Genes Dev, 12, 34-44.
Lambert, P.F., Dostatni, N., McBride, A.A., Yaniv, M., Howley, P.M. and Arcangioli, B. (1989) Functional analysis of the papilloma virus E2 trans-activator in Saccharomyces cerevisiae. Genes & Dev., 3, 38-48.
Lamberti, C., Morissey, L.C., Grossman, S. and Androphy, E.J. (1990) Transcriptional activation by the papillomavirus E6 zinc finger oncoprotein. EMBO J., 9, 1907-1913.
Lamond, A.I. and Earnshaw, W.C. (1998) Structure and function in the nucleus. Science, 280, 547-553.
Lane, D.P. and Crawford, L.V. (1979) T antigen is bound to a host protein in SV40-transformed cells. Nature, 278, 261-263.
Lang, D., Gebert, S., Arlt, H. and Stamminger, T. (1995) Functional interaction between the human cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB. J. Virol., 69, 6030-6037.
Lang, D. and Stamminger, T. (1994) Minor groove contacts are essential for an interaction of the human cytomegalovirus IE2 protein with its DNA target. Nucleic Acids Res., 22, 3331-3338.
Le Moal, M.A., Yaniv, M. and Thierry, F. (1994) The bovine papillomavirus type 1 (BPV1) replication protein E1 modulates transcriptional activation by interacting with BPV1 E2. J. Virol., 68, 1085-1093.
Lee, D., Sohn, H., Kalpana, G.V. and Choe, J. (1999) Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA. Nature, 399, 487-491.
Lee, J.S., See, R.H., Deng, T. and Shi, Y. (1996) Adenovirus E1A downregulates cJun- and JunB-mediated transcription by targeting their coactivator p300. Mol Cell Biol, 16, 4312-4326.
Lee, S.K., Kim, H.J., Na, S.Y., Kim, T.S., Choi, H.S., Im, S.Y. and Lee, J.W. (1998a) Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits. J Biol Chem, 273, 16651-16654.
Lee, S.S., Glaunsinger, B., Mantovani, F., Banks, L. and Javier, R.T. (2000a) Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J. Virol., 74, 9680-9693.
Lee, T.I., Causton, H.C., Holstege, F.C., Shen, W.C., Hannett, N., Jennings, E.G., Winston, F., Green, M.R. and Young, R.A. (2000b) Redundant roles for the TFIID and SAGA complexes in global transcription. Nature, 405, 701-704.
Lee, T.I. and Young, R.A. (1998b) Regulation of gene expression by TBP-associated proteins. Genes Dev, 12, 1398-1408.
Lee, T.I. and Young, R.A. (2000) Transcription of eukaryotic protein-coding genes. Annu Rev Genet, 34, 77-137.
Lefebvre, O., Steger, G. and Yaniv, M. (1997) Synergistic transcriptional-activation by the papillomavirus E2 protein occurs after DNA binding and correlates with a change in chromatin structure. J Mol Biol, 266, 465-478.
Leger, H., Sock, E., Renner, K., Grummt, F. and Wegner, M. (1995) Functional interaction between the POU domain protein Tst-1/Oct-6 and the high-mobility-group protein HMG-I/Y. Mol. Cell. Biol., 15, 3738-3747.
Lenzmeier, B.A., Giebler, H.A. and Nyborg, J.K. (1998) Human T-cell leukemia virus type 1 Tax requires direct access to DNA for recruitment of CREB binding protein to the viral promoter. Mol Cell Biol, 18, 721-731.
Lever, M.A., Th'ng, J.P., Sun, X. and Hendzel, M.J. (2000) Rapid exchange of histone H1.1 on chromatin in living human cells. Nature, 408, 873-876.
Li, L., Yoder, K., Hansen, M.S., Olvera, J., Miller, M.D. and Bushman, F.D. (2000) Retroviral cDNA integration: stimulation by HMG I family proteins. J. Virol., 74, 10965-10974.
Littlefield, O., Korkhin, Y. and Sigler, P.B. (1999) The structural basis for the oriented assembly of a TBP/TFB/promoter complex. Proc Natl Acad Sci U S A, 96, 13668-13673.
Liu, J.S., Kuo, S.R., Makhov, A.M., Cyr, D.M., Griffith, J.D., Broker, T.R. and Chow, L.T. (1998) Human Hsp70 and Hsp40 chaperone proteins facilitate human papillomavirus-11 E1 protein binding to the origin and stimulate cell- free DNA replication. J Biol Chem, 273, 30704-30712.
Lively, T.N., Ferguson, H.A., Galasinski, S.K., Seto, A.G. and Goodrich, J.A. (2001) c-Jun binds the n terminus of human tafii250 to derepress rna polymerase ii transcription in vitro. J Biol Chem, 276, 25582-25588.
Lo, W.S., Trievel, R.C., Rojas, J.R., Duggan, L., Hsu, J.Y., Allis, C.D., Marmorstein, R. and Berger, S.L. (2000) Phosphorylation of serine 10 in histone H3 is functionally linked in vitro and in vivo to Gcn5-mediated acetylation at lysine 14. Mol Cell, 5, 917-926.
Love, J.J., Li, X., Case, D.A., Giese, K., Grosschedl, R. and Wright, P.E. (1995) Structural basis for DNA bending by the architectural transcription factor LEF-1. Nature, 376, 791-795.
Luger, K., Mader, A.W., Richmond, R.K., Sargent, D.F. and Richmond, T.J. (1997) Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature, 389, 251-260.
Lukac, D.M., Harel, N.Y., Tanese, N. and Alwine, J.C. (1997) TAF-like functions of human cytomegalovirus immediate-early proteins. J. Virol., 71, 7227-7239.
Lundblad, J.R., Kwok, R.P., Laurance, M.E., Harter, M.L. and Goodman, R.H. (1995) Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature, 374, 85-88.
Lusky, M., Hurwitz, J. and Seo, Y.S. (1993) Cooperative assembly of the bovine papilloma virus E1 and E2 proteins on the replication origin requires an intact E2 binding site. J Biol Chem, 268, 15795-15803.
Mack, D.H. and Laimins, L.A. (1991) A keratinocyte-specific transcription factor, KRF-1, interacts with AP- 1 to activate expression of human papillomavirus type 18 in squamous epithelial cells. Proc Natl Acad Sci U S A, 88, 9102-9106.
Maher, J.F. and Nathans, D. (1996) Multivalent DNA-binding properties of the HMG-1 proteins. Proc Natl Acad Sci U S A, 93, 6716-6720.
Maki, Y., Bos, T.J., Davis, C., Starbuck, M. and Vogt, P.K. (1987) Avian sarcoma virus 17 carries the jun oncogene. Proc Natl Acad Sci U S A, 84, 2848-2852.
Mancebo, H.S., Lee, G., Flygare, J., Tomassini, J., Luu, P., Zhu, Y., Peng, J., Blau, C., Hazuda, D., Price, D. and Flores, O. (1997) P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev, 11, 2633-2644.
Mannhardt, B., Weinzimer, S.A., Wagner, M., Fiedler, M., Cohen, P., Jansen-Durr, P. and Zwerschke, W. (2000) Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3. Mol Cell Biol, 20, 6483-6495.
Marecki, S., Riendeau, C.J., Liang, M.D. and Fenton, M.J. (2001) Pu.1 and multiple ifn regulatory factor proteins synergize to mediate transcriptional activation of the human il-1beta gene. J Immunol, 166, 6829-6838.
Marmorstein, R. and Roth, S.Y. (2001) Histone acetyltransferases: function, structure, and catalysis. Curr Opin Genet Dev, 11, 155-161.
Martin, M.L., Lieberman, P.M. and Curran, T. (1996) Fos-Jun dimerization promotes interaction of the basic region with TFIIE-34 and TFIIF. Mol Cell Biol, 16, 2110-2118.
Martinez, E., Chiang, C.M., Ge, H. and Roeder, R.G. (1994) TATA-binding protein-associated factor(s) in TFIID function through the initiator to direct basal transcription from a TATA-less class II promoter. EMBO J., 13, 3115-3126.
Martinez, E., Kundu, T.K., Fu, J. and Roeder, R.G. (1998) A human SPT3-TAFII31-GCN5-L acetylase complex distinct from transcription factor IID. J Biol Chem, 273, 23781-23785.
Marzio, G., Tyagi, M., Gutierrez, M.I. and Giacca, M. (1998) HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc Natl Acad Sci U S A, 95, 13519-13524.
Masternak, K., Muhlethaler-Mottet, A., Villard, J., Zufferey, M., Steimle, V. and Reith, W. (2000) CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev, 14, 1156-1166.
Mathis, D.J. and Chambon, P. (1981) The SV40 early region TATA box is required for accurate in vitro initiation of transcription. Nature, 290, 310-315.
Maul, G.G. (1998) Nuclear domain 10, the site of DNA virus transcription and replication. Bioessays, 20, 660-667.
McNally, J.G., Muller, W.G., Walker, D., Wolford, R. and Hager, G.L. (2000) The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science, 287, 1262-1265.
McShan, G.D. and Wilson, V.G. (1997) Casein kinase II phosphorylates bovine papillomavirus type 1 E1 in vitro at a conserved motif. J Gen Virol, 78, 171-177.
McShan, G.D. and Wilson, V.G. (2000) Contribution of bovine papillomavirus type 1 E1 protein residue 48 to replication function. J Gen Virol, 81 Pt 8, 1995-2004.
Mechta-Grigoriou, F., Gerald, D. and Yaniv, M. (2001) The mammalian Jun proteins: redundancy and specificity. Oncogene, 20, 2378-2389.
Meier, J.L. and Stinski, M.F. (1996) Regulation of human cytomegalovirus immediate-early gene expression. Intervirology, 39, 331-342.
Meisterernst, M., Gander, I., Rogge, L. and Winnacker, E.L. (1988) A quantitative analysis of nuclear factor I/DNA interactions. Nucleic Acids Res., 16, 4419-4435.
Melendy, T., Sedman, J. and Stenlund, A. (1995) Cellular factors required for papillomavirus DNA replication. J. Virol., 69, 7857-7867.
Michel, B., Komarnitsky, P. and Buratowski, S. (1998) Histone-like TAFs are essential for transcription in vivo. Mol Cell, 2, 663-673.
Misteli, T. (2000) Cell biology of transcription and pre-mRNA splicing: nuclear architecture meets nuclear function. J Cell Sci, 113, 1841-1849.
Misteli, T. (2001) Protein dynamics: implications for nuclear architecture and gene expression. Science, 291, 843-847.
Misteli, T., Gunjan, A., Hock, R., Bustin, M. and Brown, D.T. (2000) Dynamic binding of histone H1 to chromatin in living cells. Nature, 408, 877-881.
Mitchell, P.J., Wang, C. and Tjian, R. (1987) Positive and negative regulation of transcription in vitro: enhancer- binding protein AP-2 is inhibited by SV40 T antigen. Cell, 50, 847-861.
Monini, P., de Lellis, L., Borgatti, P., Hassan-Omran, M. and Cassai, E. (1993) Activation of eukaryotic transcriptional promoters by the bovine papillomavirus E1-replication factor. Intervirology, 36, 245-252.
Moreau, A., Yotov, W.V., Glorieux, F.H. and St-Arnaud, R. (1998) Bone-specific expression of the alpha chain of the nascent polypeptide-associated complex, a coactivator potentiating c-Jun-mediated transcription. Mol Cell Biol, 18, 1312-1321.
Moreau, P., Hen, R., Wasylyk, B., Everett, R., Gaub, M.P. and Chambon, P. (1981) The SV40 72 base repair repeat has a striking effect on gene expression both in SV40 and other chimeric recombinants. Nucleic Acids Res., 9, 6047-6068.
Morris, P.J., Dent, C.L., Ring, C.J. and Latchman, D.S. (1993) The octamer binding site in the HPV16 regulatory region produces opposite effects on gene expression in cervical and non-cervical cells. Nucleic Acids Res., 21, 1019-1023.
Morrison, D.J., Pendergrast, P.S., Stavropoulos, P., Colmenares, S.U., Kobayashi, R. and Hernandez, N. (1999) FBI-1, a factor that binds to the HIV-1 inducer of short transcripts (IST), is a POZ domain protein. Nucleic Acids Res., 27, 1251-1262.
Muller, U., Zentgraf, H., Eicken, I. and Keller, W. (1978) Higher order structure of simian virus 40 chromatin. Science, 201, 406-415.
Munger, K., Phelps, W.C., Bubb, V., Howley, P.M. and Schlegel, R. (1989) The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol., 63, 4417-4421.
Munshi, N., Merika, M., Yie, J., Senger, K., Chen, G. and Thanos, D. (1998) Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. Mol Cell, 2, 457-467.
Nagata, K., Guggenheimer, R.A., Enomoto, T., Lichy, J.H. and Hurwitz, J. (1982) Adenovirus DNA replication in vitro: identification of a host factor that stimulates synthesis of the preterminal protein-dCMP complex. Proc Natl Acad Sci U S A, 79, 6438-6442.
Naltner, A., Wert, S., Whitsett, J.A. and Yan, C. (2000) Temporal/spatial expression of nuclear receptor coactivators in the mouse lung. Am J Physiol Lung Cell Mol Physiol, 279, L1066-1074.
Ndisang, D., Budhram-Mahadeo, V., Singer, A. and Latchman, D.S. (2000) Widespread elevated expression of the human papilloma virus (HPV)- activating cellular transcription factor Brn-3a in the cervix of women with CIN3 (cervical intraepithelial neoplasia stage 3). Clin Sci (Colch), 98, 601-602.
Nehls, M.C., Rippe, R.A., Veloz, L. and Brenner, D.A. (1991) Transcription factors nuclear factor I and Sp1 interact with the murine collagen alpha 1 (I) promoter. Mol Cell Biol, 11, 4065-4073.
Nelson, J.A., Gnann, J.W., Jr. and Ghazal, P. (1990) Regulation and tissue-specific expression of human cytomegalovirus. Curr Top Microbiol Immunol, 154, 75-100.
O'Connor, M. and Bernard, H.U. (1995b) Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element. Virology, 207, 77-88.
O'Connor, M., Chan, S. and Bernard, H.U. (1995a) Transcription factor binding sites in the long control region of genital HPVs. In Myers, G., Bernard, H.U., Delius, H., Baker, K., Icenogle, J., Halpern, A. and Wheeler, C. (eds.), Human papillomaviruses, 1995 compendium, partIII. Los Alamos National Laboratory, Los Alamos, N.Mex., pp. 21-40.
O'Shea, E.K., Rutkowski, R., Stafford, W.F., 3rd and Kim, P.S. (1989) Preferential heterodimer formation by isolated leucine zippers from fos and jun. Science, 245, 646-648.
Ogryzko, V.V., Kotani, T., Zhang, X., Schiltz, R.L., Howard, T., Yang, X.J., Howard, B.H., Qin, J. and Nakatani, Y. (1998) Histone-like TAFs within the PCAF histone acetylase complex. Cell, 94, 35-44.
Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H. and Nakatani, Y. (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell, 87, 953-959.
Oh, S.T., Kyo, S. and Laimins, L.A. (2001) Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites. J. Virol., 75, 5559-5566.
Orphanides, G. and Reinberg, D. (2000) RNA polymerase II elongation through chromatin. Nature, 407, 471-475.
Orth, G., Favre, M., Majewski, S., Jablonska, S., Antonsson, A., Forslund, O., Hansson, B.G., Ekberg, H. and Sterner, G. (2001) Epidermodysplasia Verruciformis Defines a Subset of Cutaneous Human Papillomaviruses. J. Virol., 75, 4952-4953.
Ozbun, M.A. and Meyers, C. (1998) Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification. Virology, 248, 218-230.
Parada, C.A. and Roeder, R.G. (1996) Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature, 384, 375-378.
Park, J.S., Kim, E.J., Lee, J.Y., Sin, H.S., Namkoong, S.E. and Um, S.J. (2001) Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins. Int J Cancer, 91, 822-827.
Patel, D., Huang, S.M., Baglia, L.A. and McCance, D.J. (1999) The E6 protein of human papillomavirus type 16 binds to and inhibits co- activation by CBP and p300. EMBO J., 18, 5061-5072.
Patikoglou, G. and Burley, S.K. (1997) Eukaryotic transcription factor-DNA complexes. Annu Rev Biophys Biomol Struct, 26, 289-325.
Pederson, T. (2000) Diffusional protein transport within the nucleus: a message in the medium. Nat Cell Biol, 2, E73-74.
Peng, Y.C., Breiding, D.E., Sverdrup, F., Richard, J. and Androphy, E.J. (2000) AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins. J. Virol., 74, 5872-5879.
Penrose, K.J. and McBride, A.A. (2000) Proteasome-mediated degradation of the papillomavirus E2-TA protein is regulated by phosphorylation and can modulate viral genome copy number. J. Virol., 74, 6031-6038.
Pereira, L.A., Bentley, K., Peeters, A., Churchill, M.J. and Deacon, N.J. (2000) A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res., 28, 663-668.
Phelps, W.C., Yee, C.L., Munger, K. and Howley, P.M. (1988) The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell, 53, 539-547.
Pöhler, J.R., Norman, D.G., Bramham, J., Bianchi, M.E. and Lilley, D.M. (1998) HMG box proteins bind to four-way DNA junctions in their open conformation. EMBO J., 17, 817-826.
Pombo, A., Cuello, P., Schul, W., Yoon, J.B., Roeder, R.G., Cook, P.R. and Murphy, S. (1998) Regional and temporal specialization in the nucleus: a transcriptionally-active nuclear domain rich in PTF, Oct1 and PIKA antigens associates with specific chromosomes early in the cell cycle. EMBO J., 17, 1768-1778.
Pombo, A., Jones, E., Iborra, F.J., Kimura, H., Sugaya, K., Cook, P.R. and Jackson, D.A. (2000) Specialized transcription factories within mammalian nuclei. Crit Rev Eukaryot Gene Expr, 10, 21-29.
Pontiggia, A., Rimini, R., Harley, V.R., Goodfellow, P.N., Lovell-Badge, R. and Bianchi, M.E. (1994) Sex-reversing mutations affect the architecture of SRY-DNA complexes. EMBO J., 13, 6115-6124.
Postnikov, Y.V., Trieschmann, L., Rickers, A. and Bustin, M. (1995) Homodimers of chromosomal proteins HMG-14 and HMG-17 in nucleosome cores. J Mol Biol, 252, 423-432.
Pugh, B.F. (2000) Control of gene expression through regulation of the TATA-binding protein. Gene, 255, 1-14.
Rachez, C. and Freedman, L.P. (2000) Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions. Gene, 246, 9-21.
Rangasamy, D. and Wilson, V.G. (2000) Bovine papillomavirus E1 protein is sumoylated by the host cell Ubc9 protein. J Biol Chem, 275, 30487-30495.
Rank, N.M. and Lambert, P.F. (1995) Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB. J. Virol., 69, 6323-6334.
Raval, A., Howcroft, T.K., Weissman, J.D., Kirshner, S., Zhu, X.S., Yokoyama, K., Ting, J. and Singer, D.S. (2001) Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses a promoter requirement for TAF(II)250. Mol Cell, 7, 105-115.
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B.D., Sun, Z.W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C.P., Allis, C.D. and Jenuwein, T. (2000) Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature, 406, 593-599.
Read, C.M., Cary, P.D., Crane-Robinson, C., Driscoll, P.C. and Norman, D.G. (1993) Solution structure of a DNA-binding domain from HMG1. Nucleic Acids Res., 21, 3427-3436.
Reed, S.I., Stark, G.R. and Alwine, J.C. (1976) Autoregulation of simian virus 40 gene A by T antigen. Proc Natl Acad Sci U S A, 73, 3083-3087.
Reeves, R. and Nissen, M.S. (1990) The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J Biol Chem, 265, 8573-8582.
Reid, J.L., Bannister, A.J., Zegerman, P., Martinez-Balbas, M.A. and Kouzarides, T. (1998) E1A directly binds and regulates the P/CAF acetyltransferase. EMBO J., 17, 4469-4477.
Reifsnyder, C., Lowell, J., Clarke, A. and Pillus, L. (1996) Yeast SAS silencing genes and human genes associated with AML and HIV-1 Tat interactions are homologous with acetyltransferases. Nat Genet, 14, 42-49.
Reinberg, D., Orphanides, G., Ebright, R., Akoulitchev, S., Carcamo, J., Cho, H., Cortes, P., Drapkin, R., Flores, O., Ha, I., Inostroza, J.A., Kim, S., Kim, T.K., Kumar, P., Lagrange, T., LeRoy, G., Lu, H., Ma, D.M., Maldonado, E., Merino, A., Mermelstein, F., Olave, I., Sheldon, M., Shiekhattar, R., Zawel, L. and et al. (1998) The RNA polymerase II general transcription factors: past, present, and future. Cold Spring Harb Symp Quant Biol, 63, 83-103.
Reinstein, E., Scheffner, M., Oren, M., Ciechanover, A. and Schwartz, A. (2000) Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue. Oncogene, 19, 5944-5950.
Rey, O., Lee, S. and Park, N.H. (2000) Human papillomavirus type 16 E7 oncoprotein represses transcription of human fibronectin. J. Virol., 74, 4912-4918.
Ristiniemi, J. and Oikarinen, J. (1989) Histone H1 binds to the putative nuclear factor I recognition sequence in the mouse alpha 2(I) collagen promoter. J Biol Chem, 264, 2164-2174.
Romanczuk, H. and Howley, P.M. (1992) Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc. Natl. Acad. Sci. USA, 89, 3159-3163.
Romanczuk, H., Thierry, F. and Howley, P.M. (1990) Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J. Virol., 64, 2849-2859.
Royer, H.D., Freyaldenhoven, M.P., Napierski, I., Spitkovsky, D.D., Bauknecht, T. and Dathan, N. (1991) Delineation of human papillomavirus type 18 enhancer binding proteins: the intracellular distribution of a novel octamer binding protein p92 is cell cycle regulated. Nucleic Acids Res., 19, 2363-2371.
Ryseck, R.P. and Bravo, R. (1991) c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins. Oncogene, 6, 533-542.
Saragosti, S., Moyne, G. and Yaniv, M. (1980) Absence of nucleosomes in a fraction of SV40 chromatin between the origin of replication and the region coding for the late leader RNA. Cell, 20, 65-73.
Sarnow, P., Ho, Y.S., Williams, J. and Levine, A.J. (1982) Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell, 28, 387-394.
Schlegel, R., Wade, G.M., Rabson, M.S. and Yang, Y.C. (1986) The E5 transforming gene of bovine papillomavirus encodes a small, hydrophobic polypeptide. Science, 233, 464-467.
Schuermann, M., Hunter, J.B., Hennig, G. and Muller, R. (1991) Non-leucine residues in the leucine repeats of Fos and Jun contribute to the stability and determine the specificity of dimerization. Nucleic Acids Res., 19, 739-746.
Schul, W., van Der Kraan, I., Matera, A.G., van Driel, R. and de Jong, L. (1999) Nuclear domains enriched in RNA 3'-processing factors associate with coiled bodies and histone genes in a cell cycle-dependent manner. Mol Biol Cell, 10, 3815-3824.
Schwarz, E., Freese, U.K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A. and zur Hausen, H. (1985) Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature, 314, 111-114.
Sedman, J. and Stenlund, A. (1995) Co-operative interaction between the initiator E1 and the transcriptional activator E2 is required for replicator specific DNA replication of bovine papillomavirus in vivo and in vitro. EMBO J., 14, 6218-6228.
Sedman, J. and Stenlund, A. (1998) The papillomavirus E1 protein forms a DNA-dependent hexameric complex with ATPase and DNA helicase activities. J. Virol., 72, 6893-6897.
Seeler, J.S. and Dejean, A. (1999) The PML nuclear bodies: actors or extras? Curr Opin Genet Dev, 9, 362-367.
Seo, Y.S., Muller, F., Lusky, M. and Hurwitz, J. (1993) Bovine papilloma virus (BPV)-encoded E1 protein contains multiple activities required for BPV DNA replication. Proc Natl Acad Sci U S A, 90, 702-706.
Shen, X., Yu, L., Weir, J.W. and Gorovsky, M.A. (1995) Linker histones are not essential and affect chromatin condensation in vivo. Cell, 82, 47-56.
Sheridan, P.L., Sheline, C.T., Cannon, K., Voz, M.L., Pazin, M.J., Kadonaga, J.T. and Jones, K.A. (1995) Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome- assembled DNA in vitro. Genes Dev, 9, 2090-2104.
Smale, S.T. and Baltimore, D. (1989) The "initiator" as a transcription control element. Cell, 57, 103-113.
Smale, S.T., Jain, A., Kaufmann, J., Emami, K.H., Lo, K. and Garraway, I.P. (1998) The initiator element: a paradigm for core promoter heterogeneity within metazoan protein-coding genes. Cold Spring Harb Symp Quant Biol, 63, 21-31.
Smeal, T., Angel, P., Meek, J. and Karin, M. (1989) Different requirements for formation of Jun: Jun and Jun: Fos complexes. Genes Dev, 3, 2091-2100.
Somasundaram, K. and El-Deiry, W.S. (1997) Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region. Oncogene, 14, 1047-1057.
Southern, S.A., Noya, F., Meyers, C., Broker, T.R., Chow, L.T. and Herrington, C.S. (2001) Tetrasomy is induced by human papillomavirus type 18 E7 gene expression in keratinocyte raft cultures. Cancer Res, 61, 4858-4863.
Spalholz, B.A., Yang, Y.C. and Howley, P.M. (1985) Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product. Cell, 42, 183-191.
Spencer, T.E., Jenster, G., Burcin, M.M., Allis, C.D., Zhou, J., Mizzen, C.A., McKenna, N.J., Onate, S.A., Tsai, S.Y., Tsai, M.J. and O'Malley, B.W. (1997) Steroid receptor coactivator-1 is a histone acetyltransferase. Nature, 389, 194-198.
Stein, R.W., Corrigan, M., Yaciuk, P., Whelan, J. and Moran, E. (1990) Analysis of E1A-mediated growth regulation functions: binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity. J. Virol., 64, 4421-4427.
Stenoien, D.L., Nye, A.C., Mancini, M.G., Patel, K., Dutertre, M., O'Malley, B.W., Smith, C.L., Belmont, A.S. and Mancini, M.A. (2001) Ligand-Mediated Assembly and Real-Time Cellular Dynamics of Estrogen Receptor alpha-Coactivator Complexes in Living Cells. Mol Cell Biol, 21, 4404-4412.
Strahl, B.D. and Allis, C.D. (2000) The language of covalent histone modifications. Nature, 403, 41-45.
Sturm, R.A. and Herr, W. (1988) The POU domain is a bipartite DNA-binding structure. Nature, 336, 601-604.
Sun, H.B., Shen, J. and Yokota, H. (2000) Size-dependent positioning of human chromosomes in interphase nuclei. Biophys J, 79, 184-190.
Swift, F.V., Bhat, K., Younghusband, H.B. and Hamada, H. (1987) Characterisation of a cell-type specific enhancer found in the human papillomavirus type 18 genome. EMBO J., 6, 1339-1344.
Swindle, C.S. and Engler, J.A. (1998) Association of the human papillomavirus type 11 E1 protein with histone H1. J. Virol., 72, 1994-2001.
Szekely, L., Selivanova, G., Magnusson, K.P., Klein, G. and Wiman, K.G. (1993) EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci U S A, 90, 5455-5459.
Szentirmay, M.N. and Sawadogo, M. (2000) Spatial organization of RNA polymerase II transcription in the nucleus. Nucleic Acids Res., 28, 2019-2025.
Thanos, D. and Maniatis, T. (1995) Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell, 83, 1091-1100.
Thierry, F., Dostatni, N., Arnos, F. and Yaniv, M. (1990) Cooperative activation of transcription by bovine papillomavirus type 1 E2 can occur over a large distance. Mol. Cell. Biol., 10, 4431-4437.
Thierry, F., Heard, J.M., Dartmann, K. and Yaniv, M. (1987b) Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigens. J. Virol., 61, 134-142.
Thierry, F. and Howley, P.M. (1991) Functional analysis of E2-mediated repression of the HPV18 P105 promoter. New Biol, 3, 90-100.
Thierry, F., Spyrou, G., Yaniv, M. and Howley, P. (1992) Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes. J. Virol., 66, 3740-3748.
Thierry, F. and Yaniv, M. (1987a) The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO J., 6, 3391-3397.
Thompson, D.A., Zacny, V., Belinsky, G.S., Classon, M., Jones, D.L., Schlegel, R. and Munger, K. (2001) The HPV E7 oncoprotein inhibits tumor necrosis factor alpha-mediated apoptosis in normal human fibroblasts. Oncogene, 20, 3629-3640.
Trieschmann, L., Postnikov, Y.V., Rickers, A. and Bustin, M. (1995) Modular structure of chromosomal proteins HMG-14 and HMG-17: definition of a transcriptional enhancement domain distinct from the nucleosomal binding domain. Mol Cell Biol, 15, 6663-6669.
Tsai, F.T. and Sigler, P.B. (2000) Structural basis of preinitiation complex assembly on human pol II promoters. EMBO J., 19, 25-36.
Uittenbogaard, M.N., Giebler, H.A., Reisman, D. and Nyborg, J.K. (1995) Transcriptional repression of p53 by human T-cell leukemia virus type I Tax protein. J Biol Chem, 270, 28503-28506.
Ustav, E., Ustav, M., Szymansky, P. and Stenlund, A. (1993) The bovine papillomavirus origin of replication requires a binding site for the E2 transcriptional activator. Proc. Natl. Acad. Sci. USA, 90, 898-902.
Ustav, M. and Stenlund, A. (1991) Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J., 10, 449-457.
Van Beveren, C., van Straaten, F., Curran, T., Muller, R. and Verma, I.M. (1983) Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell, 32, 1241-1255.
Van Lint, C., Burny, A. and Verdin, E. (1991) The intragenic enhancer of human immunodeficiency virus type 1 contains functional AP-1 binding sites. J. Virol., 65, 7066-7072.
Vasseur, M. (1989) Les virus oncogènes. Editions Hermann.
Vaudin, P., Delanoue, R., Davidson, I., Silber, J. and Zider, A. (1999) TONDU (TDU), a novel human protein related to the product of vestigial (vg) gene of Drosophila melanogaster interacts with vertebrate TEF factors and substitutes for Vg function in wing formation. Development, 126, 4807-4816.
Veldman, T., Horikawa, I., Barrett, J.C. and Schlegel, R. (2001) Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J. Virol., 75, 4467-4472.
Verrijzer, C.P. and Tjian, R. (1996) TAFs mediate transcriptional activation and promoter selectivity. Trends Biochem Sci, 21, 338-342.
Veschambre, P., Roisin, A. and Jalinot, P. (1997) Biochemical and functional interaction of the human immunodeficiency virus type 1 Tat transactivator with the general transcription factor TFIIB. J Gen Virol, 78, 2235-2245.
Vogt, P.K., Bos, T.J. and Doolittle, R.F. (1987) Homology between the DNA-binding domain of the GCN4 regulatory protein of yeast and the carboxyl-terminal region of a protein coded for by the oncogene jun. Proc Natl Acad Sci U S A, 84, 3316-3319.
Volpi, E.V., Chevret, E., Jones, T., Vatcheva, R., Williamson, J., Beck, S., Campbell, R.D., Goldsworthy, M., Powis, S.H., Ragoussis, J., Trowsdale, J. and Sheer, D. (2000) Large-scale chromatin organization of the major histocompatibility complex and other regions of human chromosome 6 and its response to interferon in interphase nuclei. J Cell Sci, 113, 1565-1576.
von Mikecz, A., Zhang, S., Montminy, M., Tan, E.M. and Hemmerich, P. (2000) CREB-binding protein (CBP)/p300 and RNA polymerase II colocalize in transcriptionally active domains in the nucleus. J Cell Biol, 150, 265-273.
Walters, M.C., Fiering, S., Eidemiller, J., Magis, W., Groudine, M. and Martin, D.I. (1995) Enhancers increase the probability but not the level of gene expression. Proc Natl Acad Sci U S A, 92, 7125-7129.
Waltzer, L., Logeat, F., Brou, C., Israel, A., Sergeant, A. and Manet, E. (1994) The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. EMBO J., 13, 5633-5638.
Webster, K., Parish, J., Pandya, M., Stern, P.L., Clarke, A.R. and Gaston, K. (2000) The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway. J Biol Chem, 275, 87-94.
Webster, K., Taylor, A. and Gaston, K. (2001) Oestrogen and progesterone increase the levels of apoptosis induced by the human papillomavirus type 16 E2 and E7 proteins. J Gen Virol, 82, 201-213.
Wei, P., Garber, M.E., Fang, S.M., Fischer, W.H. and Jones, K.A. (1998) A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell, 92, 451-462.
Weintraub, H. (1988) Formation of stable transcription complexes as assayed by analysis of individual templates. Proc Natl Acad Sci U S A, 85, 5819-5823.
Wells, S.I., Francis, D.A., Karpova, A.Y., Dowhanick, J.J., Benson, J.D. and Howley, P.M. (2000) Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways. EMBO J., 19, 5762-5771.
Wen, S.C., Roder, K., Hu, K.Y., Rombel, I., Gavva, N.R., Daftari, P., Kuo, Y.Y., Wang, C. and Shen, C.K. (2000) Loading of DNA-binding factors to an erythroid enhancer. Mol Cell Biol, 20, 1993-2003.
Werness, B.A., Levine, A.J. and Howley, P.M. (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science, 248, 76-79.
Whitley, M.Z., Thanos, D., Read, M.A., Maniatis, T. and Collins, T. (1994) A striking similarity in the organization of the E-selectin and beta interferon gene promoters. Mol Cell Biol, 14, 6464-6475.
Wienzek, S. and Dobbelstein, M. (2001) Viral and cellular factors that target the promyelocytic leukemia oncogenic domains strongly activate a glucocorticoid-responsive promoter. J. Virol., 75, 5391-5397.
Wildeman, A.G. (1988) Regulation of SV40 early gene expression. Biochem Cell Biol, 66, 567-577.
Wittschieben, B.O., Otero, G., de Bizemont, T., Fellows, J., Erdjument-Bromage, H., Ohba, R., Li, Y., Allis, C.D., Tempst, P. and Svejstrup, J.Q. (1999) A novel histone acetyltransferase is an integral subunit of elongating RNA polymerase II holoenzyme. Mol Cell, 4, 123-128.
Wolffe, A.P. and Hayes, J.J. (1999) Chromatin disruption and modification. Nucleic Acids Res., 27, 711-720.
Wu, D.Y., Krumm, A. and Schubach, W.H. (2000) Promoter-specific targeting of human SWI-SNF complex by Epstein-Barr virus nuclear protein 2. J. Virol., 74, 8893-8903.
Wu-Baer, F., Sigman, D. and Gaynor, R.B. (1995) Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat. Proc Natl Acad Sci U S A, 92, 7153-7157.
Xiao, H., Lis, J.T., Greenblatt, J. and Friesen, J.D. (1994) The upstream activator CTF/NF1 and RNA polymerase II share a common element involved in transcriptional activation. Nucleic Acids Res., 22, 1966-1973.
Xiao, J.H., Davidson, I., Matthes, H., Garnier, J.M. and Chambon, P. (1991) Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell, 65, 551-568.
Xu, Z., Mizuguchi, H., Ishii-Watabe, A., Uchida, E., Mayumi, T. and Hayakawa, T. (2001) Optimization of transcriptional regulatory elements for constructing plasmid vectors. Gene, 272, 149-156.
Yamada, K., Tanaka, T. and Noguchi, T. (1997) Members of the nuclear factor 1 family and hepatocyte nuclear factor 4 bind to overlapping sequences of the L-II element on the rat pyruvate kinase L gene promoter and regulate its expression. Biochem J, 324, 917-925.
Yaniv, M. and Cereghini, S. (1986) Structure of transcriptionally active chromatin. CRC Crit Rev Biochem, 21, 1-26.
Yie, J., Merika, M., Munshi, N., Chen, G. and Thanos, D. (1999) The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome. EMBO J., 18, 3074-3089.
Yoon, C.S., Kim, K.D., Park, S.N. and Cheong, S.W. (2001) alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP. Biochem Biophys Res Commun, 283, 668-673.
Yu, X., Li, P., Roeder, R.G. and Wang, Z. (2001) Inhibition of Androgen Receptor-Mediated Transcription by Amino-Terminal Enhancer of split. Mol Cell Biol, 21, 4614-4625.
Yukawa, K., Butz, K., Yasui, T., Kikutani, H. and Hoppe-Seyler, F. (1996) Regulation of human papillomavirus transcription by the differentiation-dependent epithelial factor Epoc-1/skn-1a. J. Virol., 70, 10-16.
Zanardi, T.A., Stanley, C.M., Saville, B.M., Spacek, S.M. and Lentz, M.R. (1997) Modulation of bovine papillomavirus DNA replication by phosphorylation of the viral E1 protein. Virology, 228, 1-10.
Zerby, D., Chen, C.J., Poon, E., Lee, D., Shiekhattar, R. and Lieberman, P.M. (1999) The amino-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus. Mol Cell Biol, 19, 1617-1626.
Zhou, H.J., Wong, C.M., Chen, J.H., Qiang, B.Q., Yuan, J.G. and Jin, D.Y. (2001) Inhibition of LZIP-mediated transcription through direct interaction with a novel host cell factor-like protein. J Biol Chem, 30, 30.
Zimmermann, H., Koh, C.H., Degenkolbe, R., O'Connor, M.J., Muller, A., Steger, G., Chen, J.J., Lui, Y., Androphy, E. and Bernard, H.U. (2000) Interaction with CBP/p300 enables the bovine papillomavirus type 1 E6 oncoprotein to downregulate CBP/p300-mediated transactivation by p53. J Gen Virol, 81, 2617-2623.
Zou, N., Lin, B.Y., Duan, F., Lee, K.Y., Jin, G., Guan, R., Yao, G., Lefkowitz, E.J., Broker, T.R. and Chow, L.T. (2000) The hinge of the human papillomavirus type 11 E2 protein contains major determinants for nuclear localization and nuclear matrix association. J. Virol., 74, 3761-3770.
Zwilling, S., Konig, H. and Wirth, T. (1995) High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. EMBO J., 14, 1198-1208.